Viewing Study NCT06207461



Ignite Creation Date: 2024-05-06 @ 7:58 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06207461
Status: WITHDRAWN
Last Update Posted: 2024-01-30
First Post: 2023-12-03

Brief Title: Traditional Chinese Acupoint Massage for Gastrointestinal Function Recovery
Sponsor: Wuhan Union Hospital China
Organization: Wuhan Union Hospital China

Study Overview

Official Title: Effects of Traditional Chinese Acupoint Massage on Gastrointestinal Function Recovery of ICU Patients a Single-center Prospective Non-blind Randomized Study
Status: WITHDRAWN
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Medical ethics have yet to be passed
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients in the intensive care unit ICU are often at risk of gastrointestinal dysfunction and malnutrition Gastrointestinal dysfunction was associated with poor clinical outcomes including prolonged mechanical ventilation prolonged ICU stay and increased 90-day mortality

There have been some clinical studies investigating the effects of traditional Chinese acupoint massage acupuncture or moxibustion of 7 acupoints Zhongwan Point CV12 Tianshu Point ST25 Qihai Point CV6 Zusanli point ST36 Shangjuxu Point ST37 Neiguan Point PC6 and Hegu Point LI4 on gastrointestinal function recovery Gastrointestinal dysfunction could be improved by stimulating single acupoint or combining multiple acupoints and the effects of combined stimulation of multiple acupoints was better for the improvement of gastrointestinal dysfunction

This project aims to study the effects of traditional Chinese acupoint massage acupuncture or moxibustion of 7 acupoints Zhongwan Point CV12 Tianshu Point ST25 Qihai Point CV6 Zusanli point ST36 Shangjuxu Point ST37 Neiguan Point PC6 and Hegu Point LI4 on the 28-day survival and the gastrointestinal function recovery in critically ill patients with with gastrointestinal dysfunction caused by medical diseases and critically ill patients with high risk of malnutrition in ICU and to observe their effects on the recovery of gastrointestinal barrier function by measuring the serum intestinal fatty acid binding protein iFABP citrulline diamine oxidase DAO and D-lactic acid Studies have shown that serum iFABP citrulline DAO and D-lactic acid could reflect the intestinal barrier function of the patients
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None